Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 1401 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024

Read more ››

By: GlobeNewswire - 10 Apr 2024

Zevra Therapeutics Refinances Existing Debt with up to $100M in Committed Capital under New Credit Facility

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Zevra Therapeutics, Inc.

Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Theratechnologies Inc.

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Cytokinetics, Inc.

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: BridgeBio Pharma, Inc.

Kura Oncology to Participate in Stifel Targeted Oncology Forum

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Kura Oncology, Inc.

Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Altamira Therapeutics Ltd.

Recce Pharmaceuticals Provides Business Update

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Recce Pharmaceuticals Ltd

Nusano to Present at Jefferies Radiopharma Innovation Summit

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Nusano, Inc

AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Adrenomed AG

Compass Therapeutics to Participate in the Stifel Targeted Oncology Days

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Compass Therapeutics, Inc.

SS Innovations’ Flagship SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures

Read more ››

By: GlobeNewswire - 10 Apr 2024

Skye Bioscience Uplists to The Nasdaq Global Market

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Skye Bioscience, Inc.

Arcutis Appoints David Topper as Chief Financial Officer

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Arcutis Biotherapeutics, Inc.

Excision BioTherapeutics Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Excision BioTherapeutics, Inc.

Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Ikena Oncology, Inc.

Elucent Medical Secures Series C Funding to Advance Oncologic Surgery Innovation

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Elucent Medical, Inc.

Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Daxor Corporation

Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Qualigen Therapeutics, Inc.

Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients

Read more ››

By: GlobeNewswire - 10 Apr 2024

Related companies: Monopar Therapeutics, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑